Abbott India posts Q4 FY25 net profit at Rs. 367.04 Cr
Alembic Pharmaceuticals receives USFDA final approval for Rivaroxaban Tablets USP
Lupin receives USFDA approval for Rivaroxaban Tablets
Punita Lal Joins Lupin Board as Additional Director
Sun Pharma gets FDA approval for new device to treat skin disease
Briefs: Dr. Reddy's Laboratories, Relonchem, Shilpa Pharma Lifesciences and Shanmuga Hospital
Hikal posts Q4 FY25 consolidated PAT at Rs. 50 Cr
Alivus Life Sciences reports Q4 FY25 PAT at Rs. 141.86 Cr
Indraprastha Medical Corporation posts Q4 FY25 PAT at Rs. 41.01 Cr
Jubilant Pharmova posts Q4 FY25 consolidated PAT at Rs. 153.6 Cr
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1747586470)
.jpg?v=1747586470)
